Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot
NCT ID: NCT00536432
Last Updated: 2012-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
93 participants
OBSERVATIONAL
2007-09-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to assess the benefit of such interventions for the right ventricular function. By performing extensive standardised examinations (including MRI, echocardiography, tissue Doppler,,3D-echocardiography, holter monitoring and quality of life assessments) before and 6 to 9 months after the re-intervention data of the right ventricular function are collected. Based on these quantitative data predictive parameters concerning the right ventricular recovery and information about the time of re-intervention should be determined.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Follow up of Post-repair Tetralogy of Fallot
NCT00266188
Investigation of Tetralogy of Fallot in Neonates
NCT06822400
Intra-Atrial vs. Extra-Cardiac Technique During Fontan Operation
NCT00266942
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
NCT04604418
The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
NCT05579964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Pulmonary valve replacement can improve haemodynamics, exercise tolerance and dysrhythmia. However, it is still unclear, which criteria best indicate the need for re-intervention, such as balloon dilatations of peripheral pulmonary stenoses, and what may be the best point in time in infancy.
The objective of this study is to assess the effectiveness of such interventions to the right ventricular function in small children. The data obtained are supposed to determine predictive parameters of the right ventricular recovery and to help to establish criteria for the necessity and time of re-intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with tetralogy of Fallot (including pulmonary atresia with vsd) after corrective operation
* Patients \< 8 years with corrective surgery and necessary re-intervention (e.g.cardiac catheter intervention or re-operation )
Exclusion Criteria
* Associated severe heart defects (e. g. AV canal)
* Other clinically relevant diseases, such as malignant tumor (in the investigating physician's assessment)
* MRI contraindication, e.g. cardiac pacemaker, implanted neurostimulators and other magnetizable foreign bodies
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Federal Ministry of Education and Research
OTHER_GOV
Competence Network for Congenital Heart Defects
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samir Sarikouch, MD
Role: PRINCIPAL_INVESTIGATOR
Medizinische Hochschule Hannover, Lower Saxony
Philipp Beerbaum, MD
Role: STUDY_CHAIR
Evelina Children's Hospital, Guy's and St. Thomas Foundation Trust, Interdisciplinary Medical Imaging Group, King's College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Freiburg, Klinik III Päd. Kardiologie
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Universitätsklinikum Tuebingen, Klinik für Kinderheilkunde und Jugendmedizin
Tübingen, Baden-Wurttemberg, Germany
Deutsches Herzzentrum Muenchen
Munich, Bavaria, Germany
Medizinische Hochschule Hannover, Pädiatrische Kardiologie und Intensivmedizin
Hanover, Lower Saxony, Germany
Herz- und Diabeteszentrum Nordrhein-Westfalen
Bad Oeynhausen, North Rhine-Westphalia, Germany
Herzzentrum Duisburg, Kinderkardiologie
Duisburg, North Rhine-Westphalia, Germany
Universitätsklinikum Essen, Klinik für Kinderkardiologie
Essen, North Rhine-Westphalia, Germany
Universitätsklinikum Muenster, Klinik für Kinderkardiologie
Münster, North Rhine-Westphalia, Germany
Deutsches Kinderherzzentrum St. Augustin
Sankt Augustin, North Rhine-Westphalia, Germany
Universitätsklinikum des Saarlandes, Klinik für Pädiatrische Kardiologie
Homburg/Saar, Saarland, Germany
Herzzentrum Leipzig, Klinik für Kinderkardiologie
Leipzig, Saxony, Germany
Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik für Kinderkardiologie
Kiel, Schleswig-Holstein, Germany
Deutsches Herzzentrum Berlin
Berlin, State of Berlin, Germany
Universitätsklinikum Charite, Campus Virchow-Klinikum, Otto-Heubner-Centrum für Kinder- und Jugendmedizin
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
click here for more information about the Competence Network for Congenital Heart Defects
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MP 4.2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.